Artificial Kidney Market Report 2026

Artificial Kidney Market Overview

• Artificial Kidney market size has reached to $11.43 billion in 2025 • Expected to grow to $21.18 billion in 2030 at a compound annual growth rate (CAGR) of 13.2% • Growth Driver: Surging Chronic Kidney Cases Propel Growth In The Artificial Kidney Market • Market Trend: Adoption Of Wearable Sorbent-Regeneration Dialysis Technology To Enhance Patient Mobility • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Kidney Market?

An artificial kidney refers to a mechanical device or system designed to perform the functions of a healthy kidney for individuals with end-stage renal disease (ESRD) or kidney failure. It functions outside the body and acts as a kidney substitute by clearing waste from circulation. It reduces the absorption of calcium ions in the gastrointestinal tract and red blood cell production. The main types of products in artificial kidneys are wearable artificial kidneys and implantable artificial kidneys. A wearable artificial kidney refers to a portable device that is designed to perform the functions of a natural kidney and is worn by the patient. It includes hemodialysis, peritoneal dialysis, and combination. The main end-users are hospitals, specialty clinics, ambulatory surgical centers, and others.

What Is The Artificial Kidney Market Growth Forecast?

The artificial kidney market size is expected to see rapid growth in the next few years. It will grow to $21.18 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing investments in bioengineered kidney research, rising demand for portable dialysis solutions, expansion of remote patient monitoring, growing focus on reducing dialysis dependency, technological progress in artificial organ development. Major trends in the forecast period include increasing development of wearable dialysis systems, rising focus on implantable artificial kidney solutions, growing integration of smart monitoring in dialysis devices, expansion of home-based dialysis technologies, enhanced emphasis on patient mobility and comfort.

Global Artificial Kidney Market Segmentation

1) By Product Type: Wearable Artificial Kidney, Implantable Artificial Kidney 2) By Technology: Hemodialysis Systems, Peritoneal Dialysis Systems 3) By End-User: Hospitals, Specialty Clinics Subsegments: 1) By Wearable Artificial Kidney: Portable Dialysis Systems, Compact Dialysis Units 2) By Implantable Artificial Kidney: Bioengineered Kidneys, Hybrid Dialysis Systems

What Is The Driver Of The Artificial Kidney Market?

The rapid increase in chronic kidney cases is expected to propel the growth of the artificial kidney market going forward. Chronic kidney disease is a long-term condition in which the kidneys gradually lose their function over time. Artificial kidneys are primarily used for chronic kidney disease treatment as they remove waste products and toxins from the body and lead to fluid retention, maintaining the proper balance of electrolytes. For instance, in June 2023, according to Kidney Research UK, a UK-based charitable organization that conducts research and advocacy efforts to improve understanding, prevention, and treatment of kidney diseases, an estimated 7.19 million people in the UK were affected by chronic kidney disease in 2023, representing more than 10% of the UK population and projected to increase to 7.61 million people by 2033. Therefore, the increasing number of cases of chronic kidney diseases drives the artificial kidney industry.

Key Players In The Global Artificial Kidney Market

Major companies operating in the artificial kidney market are Fresenius SE and Co. KGaA, Medtronic plc, Asahi Kasei Medical Co. Ltd., Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Nipro Medical Corporation, Nikkiso Co. Ltd., Kawasumi Laboratories Inc., Quanta Dialysis Technologies Ltd., Triomed AB, WearOptimo, AWAK Technologies Pvt. Ltd., Aethlon Medical Inc., Blood Purification Technologies Inc., Xcorporeal Inc., Nanodialysis B.V., Neokidney Development BV, Wearable Medical Devices Inc., Nephria Bio Inc., US Kidney Research Corporation

Global Artificial Kidney Market Trends and Insights

Major companies operating in the artificial kidney market are focusing on incorporating innovative solutions such as wearable sorbent-regeneration dialysis technology to enhance patient mobility, treatment flexibility, and overall quality of life. Wearable sorbent-regeneration dialysis technology uses a compact system that continuously cleans and reuses dialysate through sorbent cartridges, enabling capabilities such as continuous portable dialysis, significant reduction in dialysate volume, and greater independence for patients. For instance, in June 2023, AWAK Technologies, a Singapore-based medical technology company, launched AWAK PD, a wearable sorbent-regeneration peritoneal dialysis system designed to allow individuals with end-stage kidney disease to undergo dialysis while remaining mobile. The system features an ultra-portable three-kilogram design, a patented sorbent-based dialysate regeneration process that reduces fluid requirements by up to 90 percent, and a configuration recognized under the FDA Breakthrough Device program. AWAK PD improves treatment convenience, supports mobility, and enhances the overall patient experience.

What Are Latest Mergers And Acquisitions In The Artificial Kidney Market?

In April 2023, M42, a United Arab Emirates-based tech-enabled healthcare company, acquired Diaverum for an undisclosed amount from Bridgepoint. Through this acquisition, M42 would have a solid platform to expand its healthcare business, deliver innovative solutions to patients worldwide, and gain access to Diaverum's global network of clinics and patients. Diaverum is a Sweden-based healthcare company that provides dialysis using dialyzers.

Regional Outlook

North America was the largest region in the artificial kidney market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Artificial Kidney Market?

The artificial kidney market consists of sales of peritoneal dialysis systems, hemodialysis artificial kidneys, dialysis membranes, filtration systems, pumping systems, bioartificial kidneys, dialysate compartments, and semipermeable hollow fibers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.